IRBS Competitors

Delisted . USA . 
Stock . IR Biosciences Holdings
IRBSDelisted Stock  USD 0.0001  0.00  0.00%   
Analyzing IR Biosciences competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of IR Biosciences to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

IR Biosciences vs Ehouse Global Correlation

Moving together with IRBS Stock

  1.0HDVTY Henderson InvestmentPairCorr
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.000.00010.00
Details
Intrinsic
Valuation
LowRealHigh
0.000.0000850.00
Details
Naive
Forecast
LowNextHigh
0.00010.00010.0001
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.00010.00010.0001
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as IR Biosciences. Your research has to be compared to or analyzed against IR Biosciences' peers to derive any actionable benefits. When done correctly, IR Biosciences' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in IR Biosciences Holdings.

IR Biosciences Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between IR Biosciences and its competitors represents the degree of relationship between the price movements of corresponding delisted stocks. A correlation of about +1.0 implies that the price of IRBS and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of IR Biosciences Holdings does not affect the price movement of the other competitor.

High positive correlations

RGMP
+ 1.0
GSTC
BIOAF
+ 1.0
GSTC
BIOAF
+ 1.0
RGMP
NEPTF
+ 0.56
SCPX
PBLA
+ 0.5
NEPTF
AMPE
+ 0.33
GBLX
  

High negative correlations

NEPTF
- 0.48
GBLX
PBLA
- 0.41
GBLX
NEPTF
- 0.33
AMPE
PBLA
- 0.21
AMPE
SCPX
- 0.21
GBLX
AMPE
- 0.18
SCPX

Risk-Adjusted Indicators

There is a big difference between IRBS Stock performing well and IR Biosciences Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze IR Biosciences' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
GSTC  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
GBLX  11.31  3.00  0.00  1.34  0.00 
 0.00 
 66.67 
(40.00)
 176.19 
RGMP  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
SCPX  318.67  170.87  2.71  2.68  47.01 
(742.06)
 900.00 
(89.29)
 4,498 
AMPE  907.17  503.12  6.14  5.33  51.27 
(2,026)
 3,974 
(96.30)
 9,998 
BIOAF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
HTDS  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
NEPTF  9.00  3.24  0.00 (0.51) 0.00 
 0.00 
 0.00 
 0.00 
 399.00 
PBLA  366.55  193.50  2.74  2.07  34.81 
(1,046)
 363.64 
(96.08)
 6,548 
EHOS  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 

IR Biosciences Competitive Analysis

The better you understand IR Biosciences competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, IR Biosciences' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across IR Biosciences' competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
IRBS GSTC GBLX RGMP SCPX AMPE BIOAF NEPTF PBLA
 0.00 
 0.0001 
IRBS
 0.00 
 0.0001 
AngioSoma
 0.00 
 0.0005 
GBLX
 0.00 
 0.0001 
Regnum
 125.00 
 0.0009 
Scorpius
 96.15 
 0.01 
Ampio
 0.00 
 0.0002 
BiOasis
 0.00 
 0.0001 
Neptune
 70.77 
 0.01 
Panbela
Market Volatility
(90 Days Market Risk)
Very steady
Very steady
Out of control
Very steady
Out of control
Out of control
Very steady
Out of control
Out of control
Market Performance
(90 Days Performance)
Weakest
Weakest
Fair
Weakest
Solid
Solid
Weakest
Weakest
Solid
Odds of Financial Distress
(Probability Of Bankruptcy)
Hazard
High
Strong
Risky
Average
High
Risky
Unknown
Moderate
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Strong Buy
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Not Rated
Strong Sell
Cautious Hold
Strong Sell
Sell
Sell
Strong Sell
Strong Sell
Sell
Current Ratio
0.01
N/A
0.03
0.62
N/A
4.85
0.38
N/A
0.56
Net Asset
65.8 K
9
2.55 M
4.5 K
39.18 M
5.74 M
2.27 M
N/A
4.98 M
Profit Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
EBITDA
(2.85 M)
(1.21 M)
398.73 K
(112.86 K)
(26.22 M)
(8.63 M)
(3.54 M)
N/A
(34.76 M)
Current Valuation
170.83 K
9.39 M
10.19 M
4.25 M
20 M
(3.33 M)
6 M
N/A
8.64 M
Price To Book
N/A
N/A
1.08
7857.73
0.1
0.21
53.47
N/A
3.22
Operating Margin
N/A
N/A
N/A
N/A
-25.38
N/A
-11.41
N/A
N/A
Current Asset
45 K
N/A
2.2 M
N/A
N/A
29.23 M
874 K
N/A
N/A
Retained Earnings
N/A
N/A
(78.28 M)
N/A
(287.18 M)
(242.53 M)
(18.69 M)
N/A
(91.09 M)
Beta
527.47
1.17
0.56
3.46
1.42
1.95
0.39
N/A
0.83
Number Of Employees
4
6
3
1
90
6
23
N/A
6
Shares Outstanding
17.08 M
770.36 M
379.21 M
22.95 M
61.14 M
1.14 M
79.41 M
N/A
3.48 M
Cash Flow From Operations
(430.31 K)
(327 K)
(1.87 M)
(3.67 K)
(26.01 M)
(8.56 M)
(3.64 M)
N/A
(15.28 M)
Total Debt
3.61 M
20 K
397.31 K
1.53 M
28.55 M
274 K
401.76 K
N/A
6.84 M
Return On Equity
N/A
N/A
-50.98
N/A
-5.16
-1.14
N/A
N/A
-7.98
Z Score
N/A
N/A
-30.0
-79.3
N/A
N/A
-11.5
N/A
-49.78
Return On Asset
-7.92
-44.28
-0.21
-1.03
-0.57
-0.62
-0.81
N/A
-1.92
Book Value Per Share
-0.78
-0.002
-0.004
-0.045
-0.041
4.03
-0.034
N/A
-16.57
Number Of Shares Shorted
N/A
N/A
N/A
N/A
278.26 K
32.9 K
N/A
N/A
106.97 K
Current Liabilities
6.51 M
N/A
1.32 M
N/A
N/A
5.52 M
437 K
N/A
N/A
Total Asset
65.8 K
9
2.55 M
4.5 K
39.18 M
5.74 M
2.27 M
N/A
4.98 M
Target Price
2.0
N/A
N/A
N/A
5.0
2.0
0.58
N/A
410.0
Debt To Equity
N/A
N/A
1.07
N/A
N/A
0.038
0.31
N/A
N/A
Short Ratio
N/A
N/A
N/A
N/A
0.56
0.31
N/A
N/A
0.07
Shares Owned By Institutions
N/A
0.02
N/A
N/A
N/A
4.19
N/A
N/A
0.59
Market Capitalization
213.54 K
8.47 M
8.21 M
3.67 M
55.03 K
340.61 K
2.13 M
N/A
3.93 M
Price To Earnings To Growth
N/A
-0.08
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Price To Earning
N/A
N/A
4.04
N/A
N/A
28.57
13.82
N/A
N/A
Price To Sales
N/A
78200.54
1.91
3337.16
0.0228
N/A
26.52
N/A
N/A
Net Income
(5.28 M)
(1.49 M)
(530.87 K)
(117.67 K)
(34.33 T)
(8.63 M)
(2.96 M)
N/A
(34.93 M)
Earnings Per Share
N/A
-0.018
N/A
-0.024
43.0
-10.66
-0.031
N/A
-157.02
Shares Owned By Insiders
N/A
10.02
13.08
98.82
0.057
1.56
2.05
N/A
N/A
Revenue
N/A
N/A
N/A
9 K
6.24 M
N/A
37.73 K
N/A
N/A
Working Capital
(6.46 M)
N/A
881 K
N/A
(21.03 M)
3.36 M
437 K
N/A
(6.06 M)
Cash And Equivalents
N/A
12
53.96 K
1.26 M
N/A
23.25 M
764.97 K
N/A
2.53 M
Cash Per Share
N/A
N/A
N/A
0.05
N/A
0.1
0.01
N/A
0.12
Gross Profit
N/A
(2.41 K)
(881.46 K)
6.77 K
(12.39 M)
N/A
(1.15 M)
N/A
N/A
Daily Balance Of Power
0.0
0.0
0.0
0.0
9.2 T
0
0.0
0.0
9.2 T
Day Typical Price
1.0E-4
1.0E-4
5.0E-4
1.0E-4
9.0E-4
0.01
2.0E-4
1.0E-4
0.0111
Period Momentum Indicator
N/A
N/A
N/A
N/A
5.0E-4
(0.25)
N/A
N/A
0.0046
Rate Of Daily Change
1.0
1.0
1.0
1.0
2.25
0.0385
1.0
1.0
1.71
Day Median Price
1.0E-4
1.0E-4
5.0E-4
1.0E-4
9.0E-4
0.01
2.0E-4
1.0E-4
0.0111
Price Action Indicator
N/A
N/A
N/A
N/A
3.0E-4
(0.12)
N/A
N/A
0.0023
Coefficient Of Variation
N/A
N/A
798.08
N/A
388.01
325.41
N/A
1282.69
524.69
Mean Deviation
N/A
N/A
11.31
N/A
318.67
907.17
N/A
9.0
366.55
Jensen Alpha
N/A
N/A
3.0
N/A
170.87
503.12
N/A
3.24
193.5
Total Risk Alpha
N/A
N/A
1.93
N/A
141.79
429.56
N/A
1.21
148.65
Sortino Ratio
N/A
N/A
N/A
N/A
2.71
6.14
N/A
N/A
2.74
Downside Variance
N/A
N/A
N/A
N/A
4085.13
6811.56
N/A
N/A
5161.1
Standard Deviation
N/A
N/A
24.65
N/A
671.82
1648.1
N/A
39.06
1032.83
Kurtosis
N/A
N/A
13.01
N/A
26.97
17.6
N/A
53.99
30.82
Potential Upside
N/A
N/A
66.67
N/A
900.0
3974.07
N/A
N/A
363.64
Treynor Ratio
N/A
N/A
1.34
N/A
2.68
5.33
N/A
(0.51)
2.07
Maximum Drawdown
N/A
N/A
176.19
N/A
4498.0
9998.31
N/A
399.0
6548.21
Variance
N/A
N/A
607.38
N/A
451338.86
2716218.4
N/A
1525.98
1066741.48
Market Risk Adjusted Performance
N/A
N/A
1.35
N/A
2.69
5.34
N/A
(0.50)
2.08
Risk Adjusted Performance
N/A
N/A
0.1039
N/A
0.2037
0.241
N/A
0.0684
0.1533
Skewness
N/A
N/A
2.82
N/A
4.93
3.94
N/A
6.69
5.6
Semi Deviation
N/A
N/A
N/A
N/A
47.01
51.27
N/A
N/A
34.81
Information Ratio
N/A
N/A
0.1235
N/A
0.2577
0.3073
N/A
0.0768
0.1905
Value At Risk
N/A
N/A
(40.00)
N/A
(89.29)
(96.30)
N/A
N/A
(96.08)
Expected Short fall
N/A
N/A
N/A
N/A
(742.06)
(2,026)
N/A
N/A
(1,046)
Downside Deviation
N/A
N/A
N/A
N/A
63.92
82.53
N/A
N/A
71.84
Semi Variance
N/A
N/A
N/A
N/A
2210.39
2628.19
N/A
N/A
1211.75

IR Biosciences Competition Performance Charts

Five steps to successful analysis of IR Biosciences Competition

IR Biosciences' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by IR Biosciences Holdings in relation to its competition. IR Biosciences' competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of IR Biosciences in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact IR Biosciences' competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to IR Biosciences Holdings, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your IR Biosciences position

In addition to having IR Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run SRI Sustainable Growth Thematic Idea Now

SRI Sustainable Growth
SRI Sustainable Growth Theme
Socially responsible investments that include companies making a positive, sustainable or social impact and exclude those making a negative impact. The SRI Sustainable Growth theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize SRI Sustainable Growth Theme or any other thematic opportunities.
View All  Next Launch
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Other Consideration for investing in IRBS Stock

If you are still planning to invest in IR Biosciences Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the IR Biosciences' history and understand the potential risks before investing.
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
CEOs Directory
Screen CEOs from public companies around the world
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Stocks Directory
Find actively traded stocks across global markets
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY